- Original article
- Open access
- Published:
Absolute quantitation of sympathetic nerve activity using [123I] metaiodobenzylguanidine SPECT-CT in neurology
EJNMMI Reports volume 8, Article number: 15 (2024)
Abstract
Background and purpose
The ability of [123I]metaiodobenzylguanidine (MIBG) sympathetic nerve imaging with three-dimensional (3D) quantitation to clinically diagnose neurological disorders has not been evaluated. This study compared absolute heart counts calculated as mean standardized uptake values (SUVmean) using conventional planar imaging and assessed the contribution of [123I]MIBG single-photon emission computed tomography (SPECT)-CT to the diagnosis of neurological diseases.
Methods
Seventy-two patients with neurological diseases were consecutively assessed using early and delayed [123I]MIBG SPECT-CT and planar imaging. Left ventricles were manually segmented in early and delayed SPECT-CT images, then the SUVmean and washout rates (WRs) were calculated. Heart-to-mediastinum ratios (HMRs) and WRs on planar images were conventionally computed. We investigated correlations between planar HMRs and SPECT-CT SUVmeans and between WRs obtained from planar and SPECT-CT images. The cutoff for SPECT-CT WRs defined by linear regression and that of normal planar WRs derived from a database were compared with neurological diagnoses of the patients. We assigned the patients to groups according to clinical diagnoses as controls (n = 6), multiple system atrophy (MSA, n = 7), progressive supranuclear palsy (PSP, n = 17), and Parkinson’s disease or dementia with Lewy bodies (PD/DLB, n = 19), then compared SPECT-CT and planar image parameters.
Results
We found significant correlations between SPECT-CT SUVmean and planar HMR on early and delayed images (R2 = 0.69 and 0.82, p < 0.0001) and between SPECT-CT and planar WRs (R2 = 0.79, p < 0.0001). A threshold of 31% for SPECT-CT WR based on linear regression resulted in agreement between planar and SPECT-CT WR in 67 (93.1%) of 72 patients. Compared with controls, early and delayed SUVmean in patients with PSP and MSA tended more towards significance than planar HMR. This trend was similar for SPECT-CT WRs in patients with PSP.
Conclusions
Absolute heart counts and SUVmean determined using [123I]MIBG SPECT-CT correlated with findings of conventional planar images in patients with neurological diseases. Three-dimensional quantitation with [123I]MIBG SPECT-CT imaging might differentiate patients with PSP and MSA from controls.
Background
The physiological noradrenaline analog, [123I]metaiodobenzylguanidine (MIBG), tracks absorption, transit, and the subsequent vesicular storage of noradrenaline in postsynaptic sympathetic nerve terminals. It can reveal sympathetic nerve activity, integrity, and disturbances in several pathological states. Myocardial [123I]MIBG uptake and washout are clinically useful markers of neurodegenerative disorders such as dementia with Lewy bodies (DLB) and Parkinson's disease (PD), as well as for evaluating disease severity and prognosis, the effects of treatment on heart failure, and arrhythmogenic disease (Nakajima and Nakata 2015; Nakajima and Yamada 2016; McKeith et al. 2017; Travin et al. 2017; Yamada et al. 2020; Verschure et al. 2022). Heart-to-mediastinum ratios (HMR) and washout rates (WR) determined from planar images are indicators of sympathetic nerve activity (Okuda et al. 2011; Nakajima et al. 2017; Owenius et al. 2017; Bateman et al. 2019). However, although assessment protocols have been standardized, the uncertainty of HMR analysis of clinical data results in up to 40% of patients remaining in the measurement gray zone (Klene et al. 2018). Three-dimensional (3D) images generated by single-photon emission computed tomography (SPECT) can distinguish between cardiac activity and background or overlapping organs. Quantitative 3D evaluation using [123I]MIBG SPECT is feasible without CT (Chen et al. 2012; Saito et al. 2021), and Lewy body disease has been diagnosed based on the heart-to-aorta ratio using [123I]MIBG SPECT-CT (Odagiri et al. 2016), which is a relative 3D quantitation method. When attenuation is corrected using low-dose CT, absolute heart counts and standardized uptake values (SUVs) in patients with cardiac and neurological diseases can be calculated based on [123I]MIBG SPECT images (Saito et al. 2023). However, the relationship between 3D quantitation and clinical diagnoses of neurological diseases remains unknown. Here, we aimed to determine the contribution of [123I]MIBG SPECT-CT to the differential diagnosis of neurological diseases. We therefore compared clinical data generated by conventional planar image-based quantitation with absolute heart counts determined as mean SUVs (SUVmean) derived from [123I]MIBG SPECT-CT images of patients with neurological diseases.
Methods
Patients
This study initially enrolled 72 consecutive patients (average age, 69.8 ± 8.8; range, 35‒88 years; male, n = 27; female, n = 45) with neurological diagnoses at Kanazawa University Hospital between 2020 and 2022. Table 1 shows that PS/PD/DLB (n = 50) comprised Parkinson’s syndrome (PS; n = 31), PD (n = 14), DLB (n = 5), and non-PS/PD/DLB (n = 22) including familial amyloid polyneuropathy (FAP; n = 7) and other neurological diseases. A neurologist with expertise in movement disorders categorized the diagnoses based on the recommended criteria for progressive supranuclear palsy (PSP), multiple system atrophy (MSA), PD, and DLB (Gilman et al. 2008; Postuma et al. 2015; Hoglinger et al. 2017; McKeith et al. 2017). Cardiac [123I]MIBG uptake was significantly reduced to a planar delayed HMR < 1.5 in 17 patients.
[123I]MIBG image processing
All patients were evaluated using early and delayed [123I]MIBG planar and SPECT-CT imaging. A medium-energy (ME) collimator was applied to image acquisition using Symbia Intevo and Symbia Intevo Bold SPECT-CT scanners (Siemens Healthcare, Erlangen, Germany). The patients were intravenously administered with 111 MBq of [123I] MIBG, and images were acquired 15–20 (early phase) and 180–240 (delayed phase) minutes later. Planar images were acquired for 5 min using 256 × 256-matrix with a zoom factor of 1.0 (2.4-mm pixels). The SPECT images were acquired using 128 × 128-matrix with a zoom factor of 1.0 (4.8-mm pixels), 60 projections, circular orbit of 360°, rotation radius of 24 cm, and 30 s per view. The SPECT data were reconstructed by an ordered subset conjugate gradient minimizer using the xSPECT Quant algorithm. Low-dose CT images were acquired for attenuation correction after SPECT image acquisition. The CT scanning parameters were: 130 kV, 20 mA with CARE Dose 4D, 16 × 1.2 mm collimation, 0.6-s rotation, and pitch, 1.5. Multiple-energy window scatter and CT-based attenuation correction was automated.
SUVs and WRs in SPECT-CT images and left ventricular segmentation
We manually segmented entire left ventricle into regions of interest (ROI) in early and delayed SPECT-CT images as described (Saito et al. 2023). Two nuclear medicine specialists operated the SPECT and X-ray CT devices, and fusion imaging was applied to evaluate left ventricular morphology and [123I]MIBG activity, and to determine the boundaries of the left ventricle. Accumulation in the liver was clearly separated from the left ventricle for all segmentation processes. Figure 1 shows an example of 3D left ventricle segmentation. We calculated SPECT-CT SUVmean using the SUV that reflected the normalized concentration of tissue radioactivity relative to the dose and weight of the injected radioactive tracer. This value represents the average SUV of voxels within volumes of interest (VOI) that included the complete left ventricle.
The SPECT-CT WRs were calculated based on SUVmean values as:
HMRs and WRs in planar images
Early and delayed HMRs were computed using semi-automatic SmartMIBG software (PDRadiopharma, Inc., Tokyo, Japan) for the planar images while ROIs were being established. (Okuda et al. 2011). The software algorithm uses a circular heart ROI and a mediastinal ROI with a 10% body width and a 30% mediastinum height. After the heart center is adjusted, the entire procedure is automated, with manual correction as required.
Planar WRs with time-decay corrections from early and delayed heart (Hearly and Hdelayed) and mediastinal (Mearly and Mdelayed) counts were calculated as:
where t is the elapsed time (hours) between early and delayed image acquisition (Flotats et al. 2010).
Quantitative analysis of SPECT-CT and conventional planar images
We analyzed correlations between SPECT-CT SUVmean and planar HMRs in early and delayed images and between WRs derived from SPECT-CT SUVmean and planar images. Based on standard values extracted from the JSNM working group databases (n = 62), the threshold for differentiating normal from abnormal planar WR was 34.0% (Nakajima et al. 2018). We determined a SPECT-CT WR cutoff by evaluating correlations between SPECT-CT and planar WRs, then used it to categorize patients as normal or abnormal. We subsequently assessed the degree of agreement between the methodologies. We assigned the participants (n = 49) to four groups based on clinical diagnoses of: Alzheimer's disease, depression, cerebral hemorrhage, cerebral palsy, and somatoform disorders (control; n = 6), MSA (n = 7), PSP (n = 17), and PD/DLB (n = 19). Figure 2 shows the flow of patient classification into these distinct groups. The exclusion criteria included: patients with FAP (n = 7), Parkinson’s syndrome other than MSA and PSP (n = 7), unknown etiology (n = 4), amyotrophic lateral sclerosis (n = 1) or outpatients referred from other hospitals without diagnostic confirmation (n = 4). The SUVmean and WR calculated from SPECT-CT images and HMRs and WR calculated from planar images were compared among the four groups.
Statistics
All data were analyzed using JMP Pro version 17 (SAS Institute Inc., Cary, NC, USA). Data are expressed as means and standard deviations (SD). Correlations between SUVmean and HMR, and between SPECT-CT and planar WRs were assessed using t-tests and two-way analysis of variance. Values were compared between groups using t-tests. We assessed the diagnostic performance of MSA, PSP, and PD/DLB using SPECT-CT and planar images by the analysis of area under the receiver operating characteristics (ROC) curve (AUC). Values with P < 0.05 were considered significantly different.
Results
SPECT-CT SUVmean versus planar HMR and SPECT-CT WR versus planar WR
The SUVmean was calculated from early and delayed [123I]MIBG SPECT-CT images acquired from all the patients. Figure 1 shows examples of manual 3D left ventricular segmentation and the resulting SUVmean. We compared SPECT-CT SUVmean and planar HMR on early and delayed [123I]MIBG images. The early and delayed SPECT-CT SUVmean significantly correlated with planar HMR (R2 = 0.69 and 0.82, p < 0.0001; Fig. 3). We also compared SPECT-CT WRs using SUVmean and planar WR using conventional methods. significantly correlated between planar and SPECT-CT WRs (R2 = 0.79, p < 0.0001; Fig. 4). We determined a 31% threshold for SPECT-CT WRs using planar WR linear regression with a maximum standard deviation of 34% (Nakajima et al. 2018). Normal and abnormal WRs that were subsequently classified based on the cutoff values for SPECT-CT and planar WRs agreed in 67 (93.1%) of 72 patients (Table 2).
Comparison of SPECT-CT and planar image parameter values between groups
Table 3 shows comparisons of [123I]MIBG SPECT-CT and planar parameters between groups. Early and delayed SUVmean and WR in SPECT-CT images significantly differed between patients with PD/DLB and controls (p = 0.0006, p < 0.0001, and p = 0.0003, respectively). The statistical significance of early and delayed HMR and WR in planar images between patients with PD/DLB and controls was similar to that of the SPECT-CT parameters (p = 0.0153, p = 0.0021, and p = 0.0011, respectively). Early and delayed SUVmean and WRs tended to differ more than planar parameters in patients with PSP compared with controls (p = 0.195, p = 0.0845, and p = 0.0644, respectively). The trends of early and delayed SUVmeans (p = 0.125 and p = 0.132, respectively) were similar between patients with MSA and controls. The SPECT-CT parameters significantly differed between patients with PSP or MSA and those with PD/DLB, except for early SUVmean between patients with MSA and PD/DLB. Early and delayed HMRs and WRs significantly differed between planar images of patients with PSP or MSA and those with PD/DLB. No significant differences were found between PSP and MSA. Diagnoses of MSA, PSP, and PD/DLB, ROC derived using planar and SPECT-CT parameters did not significantly differ.
Discussion
The present findings revealed a close correlation between planar imaging-based quantitative and SUVmean values obtained from [123I]MIBG SPECT-CT images of patients with neurological diseases. We confirmed that [123I]MIBG SPECT-CT revealed consistently reduced uptake in patients with PD/DLB in general. Quantitative evaluation using [123I]MIBG SPECT-CT also helped to differentiate MSA and PSP from controls.
Absolute quantitation using SPECT-CT
Absolute quantitation using 3D images could be one option for analyzing cardiac sympathetic images. Standard cardiac sympathetic imaging is not completely quantitative and is assessed by comparing the heart to other tissues. Semi-quantitative standard visual scoring systems that compare the heart to the mediastinum improves visual scoring but relies on the extracardiac position as a reference area. In addition, anatomically overlapping organs on two-dimensional (2D) images are avoided on 3D images. Calculating the absolute amount of myocardial uptake using quantitative SPECT might further improve diagnostic performance by narrowing the gray zone in conventional 2D quantitative evaluation. Nuclear medicine quantitation has progressed from simple thyroid uptake measurements to PET-based kinetic and SUV analyses. The need for radionuclide therapy has primarily led to SPECT quantitation becoming more prevalent. The potential applications of absolute SPECT-CT image quantitation such as myocardial perfusion, 99mTc-Pyrophosphate scintigraphy, and cardiac sympathetic nerve imaging to diagnoses have been discussed (Ramsay and Cuscaden 2020; Dorbala et al. 2021; Lehner et al. 2022; Nakajima et al. 2023; Saito et al. 2023). These applications should become more established in the field of nuclear medicine diagnostics.
Application of SUVmean
Activity normalization within an ROI is represented by SUVs, which comprise the amount of injected activity divided by that distributed within a patient. The significant advantage of quantitative evaluation using SUVs is that the calculated values are independent of body weight. Standard uptake values vary. Here, we calculated SPECT-CT SUVmean as the average SUV of voxels inside a VOI that comprised the entire left ventricle (Saito et al. 2023). The following might offer a possible explanation. The maximum standardized uptake value (SUVmax) can serve as a quantitative measure when assessing [123I]MIBG sympathetic images. However, SUVmax is derived from a single pixel rather than an entire ROI. When SUVmax is calculated for [123I]MIBG sympathetic images of the heart, this could result in significant deviation. The myocardial uptake of [123I]MIBG is variable and can be affected by inferior deficiencies or diffusely decreased uptake with Lewy body disorders. Another reason for using SUVmean is that the connection is closer to SUVmean than SUVmax compared with 2D quantitative values in patients with neurological and cardiac disorders (Saito et al. 2023). We identified a close correlation between SUVmean and planar HMR in patients with neurological diseases. The correlation was also good for SUVmean and WRs. The SUVmean in [123I]MIBG sympathetic imaging could be a valuable quantitative indicator of myocardial accumulation. However, the average SUV depends on the definition of the ROI and might be affected by intra- and inter-observer variability.
Differentiation of PSP, MSA, and controls on cardiac sympathetic nerve images
We determined that quantifying sympathetic neural function in 3D SPECT-CT images might be useful to differentiate patients with PSP and MSA from controls. Although 3D evaluation found no significant differences, the SUVmean tended to be lower and the WR tended to be higher in patients with PSP than controls, and was stronger than the conventional 2D findings (p = 0.195, p = 0.0845 and p = 0.0644, respectively; Table 3). A trend towards lower early and delayed SUVmean values in patients with MSA versus controls was also more obvious in 3D, than conventional 2D images (p = 0.125 and p = 0.132, respectively; Table 3). Planar images of patients with PSP have revealed slightly reduced MIBG accumulation, which might be associated with brainstem atrophy (Kamada et al. 2019). Although cardiac [123I]MIBG uptake is thought to be primarily maintained in MSA with prejunctional autonomic failure, the planar HMR was decreased compared with controls during the early and delayed phases in 5 and 4 of 9 patients with Parkinson's variant of multiple system atrophy (MSA-P) (Kollensperger et al. 2007). Reduced [123I]MIBG accumulation in MSA might be partly explained by factors associated with Lewy body pathology (Nagayama et al. 2010). The elimination of organ overlaps and mediastinal dependence in 3D quantitative assessment might have resulted in a more precise reflection of sympathetic nerve function. Because the SUVmean is based on absolute quantitation and not ratios as in HMR, it has a wider range than conventional HMR values and could be subdivided into normal, PSP, MSA, and PD/DLB. Currently, HMR derived from planar images is the most popular measure of sympathetic nerve activity, whereas SPECT data are considered supplementary. However, a diagnostic system that includes SPECT might establish 3D quantitative assessment as the diagnostic standard. Moreover, data collection by tomographic imaging is a standard procedure for semiconductor SPECT systems that do not rely on traditional planar images. Consequently, direct use of SPECT images could be a practical alternative.
The future
We manually segmented the heart including the entire left ventricular cavity and the myocardium because our objective was to determine the contribution of quantified 3D values to the diagnosis of neurological diseases. We therefore compared conventional 2D, with 3D quantitative values using SPECT-CT. Isolating the myocardium using non-contrast X-ray CT is challenging. The entire left ventricle was segmented because preserved and decreased accumulation must be considered when [123I]MIBG is used to assess sympathetic nerve function. Subsequent investigations will require finding a way to separate and isolate the myocardium from the left ventricular cavity. Since manual segmentation is complicated and requires prolonged processing, integrating artificial intelligence with automatic 3D segmentation should significantly enhance convenience. Cardiac segmentation and quantitation by [123I]MIBG SPECT has been based on a convolutional neural network (Saito et al. 2021). This technique should be extended to [123I]MIBG SPECT-CT imaging using segmentation and quantitation automated by artificial intelligence.
Limitations
The possibility of unintentional selection bias could not be entirely excluded due to our small patient cohort and the retrospective, single-center study design. The current investigation is an initial attempt to assess whether quantitative 3D assessment of [123I] MIBG sympathetic images could differentiate neurological diseases based solely on their diagnoses. This study included consecutive cases with diverse backgrounds, and did not focus on a specific disorder. Our expert neurologist retrospectively determined the most likely neurological diagnoses based on clinical evaluations during hospital stays and outpatient visits. While this approach of consecutive inclusion might introduce some level of diagnostic uncertainty, it reflects real-world clinical practice. Prospective, large-scale investigations are needed to validate the diagnostic accuracy of [123I]MIBG scintigraphy using SPECT/CT to account for disease progression and severity.
Conclusions
Absolute cardiac counts and SUVs significantly correlated between [123I]MIBG SPECT-CT and conventional quantitative planar images of neurological diseases. This outcome indicated that a differential diagnosis between controls and patients with PSP and MSA would require 3D quantitative evaluation using [123I]MIBG SPECT-CT. Absolute 3D quantitation of sympathetic innervation is a viable approach that could be integrated into methods to quantify cardiac sympathetic activity.
Availability of data and materials
Without authorization from the Ethics Committees of Kanazawa University, the image datasets generated or analyzed in this research are not disclosed publicly. However, the corresponding author may provide them upon reasonable request.
Change history
06 August 2024
We have updated the journal title.
Abbreviations
- AUC:
-
Area under the ROC curve
- DLB:
-
Dementia with Lewy bodies
- HMR:
-
Heart-to-mediastinum ratio
- MIBG:
-
Metaiodobenzylguanidine
- MSA:
-
Multiple system atrophy
- PD:
-
Parkinson’s disease
- PS:
-
Parkinson’s syndrome
- SPECT:
-
Single-photon emission computed tomography
- ROC:
-
Receiver operating characteristic
- SUV:
-
Standardized uptake value
- WR:
-
Washout rates
References
Bateman TM, Ananthasubramaniam K, Berman DS, Gerson M, Gropler R, Henzlova M et al (2019) Reliability of the [123I]mIBG heart/mediastinum ratio: results of a multicenter test-retest reproducibility study. J Nucl Cardiol 26(5):1555–1565
Chen J, Folks RD, Verdes L, Manatunga DN, Jacobson AF, Garcia EV (2012) Quantitative I-123 mIBG SPECT in differentiating abnormal and normal mIBG myocardial uptake. J Nucl Cardiol 19(1):92–99
Dorbala S, Park MA, Cuddy S, Singh V, Sullivan K, Kim S et al (2021) Absolute quantitation of cardiac [99mTc]Pyrophosphate using cadmium–zinc–telluride-based SPECT/CT. J Nucl Med 62(5):716–722
Flotats A, Carrio I, Agostini D, Le Guludec D, Marcassa C, Schafers M et al (2010) Proposal for standardization of [123I]metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM cardiovascular committee and the European council of nuclear cardiology. Eur J Nucl Med Mol Imaging 37(9):1802–1812
Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71(9):670–676
Hoglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE et al (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32(6):853–864
Kamada T, Miura S, Kida H, Irie KI, Yamanishi Y, Hoshino T et al (2019) MIBG myocardial scintigraphy in progressive supranuclear palsy. J Neurol Sci 396:3–7
Klene C, Jungen C, Okuda K, Kobayashi Y, Helberg A, Mester J et al (2018) Influence of ROI definition on the heart-to-mediastinum ratio in planar [123I]MIBG imaging. J Nucl Cardiol 25(1):208–216
Kollensperger M, Seppi K, Liener C, Boesch S, Heute D, Mair KJ et al (2007) Diffusion weighted imaging best discriminates PD from MSA-P: a comparison with tilt table testing and heart MIBG scintigraphy. Mov Disord 22(12):1771–1776
Lehner S, Nowak I, Zacherl M, Brosch-Lenz J, Fischer M, Ilhan H et al (2022) Quantitative myocardial perfusion SPECT/CT for the assessment of myocardial tracer uptake in patients with three-vessel coronary artery disease: initial experiences and results. J Nucl Cardiol 29(5):2511–2520
McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D et al (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89(1):88–100
Nagayama H, Ueda M, Yamazaki M, Nishiyama Y, Hamamoto M, Katayama Y (2010) Abnormal cardiac [123I]meta-iodobenzylguanidine uptake in multiple system atrophy. Mov Disord 25(11):1744–1747
Nakajima K, Nakata T (2015) Cardiac [123I]MIBG imaging for clinical decision making: 22-year experience in Japan. J Nucl Med 56(Suppl 4):11S-19S
Nakajima K, Yamada M (2016) [123I]Meta-iodobenzylguanidine sympathetic imaging: standardization and application to neurological diseases. Chonnam Med J 52(3):145–150
Nakajima K, Scholte A, Nakata T, Dimitriu-Leen AC, Chikamori T, Vitola JV et al (2017) Cardiac sympathetic nervous system imaging with [123I]meta-iodobenzylguanidine: perspectives from Japan and Europe. J Nucl Cardiol 24(3):952–960
Nakajima K, Okuda K, Matsuo S, Wakabayashi H, Kinuya S (2018) Is [123I]metaiodobenzylguanidine heart-to-mediastinum ratio dependent on age? From Japanese society of nuclear medicine normal database. Ann Nucl Med 32(3):175–181
Nakajima K, Shibutani T, Massanes F, Shimizu T, Yoshida S, Onoguchi M et al (2023) Myocardial perfusion imaging with retrospective gating and integrated correction of attenuation, scatter, respiration, motion, and arrhythmia. J Nucl Cardiol 30(6):2773–2789
Odagiri H, Baba T, Nishio Y, Iizuka O, Matsuda M, Inoue K et al (2016) On the utility of MIBG SPECT/CT in evaluating cardiac sympathetic dysfunction in lewy body diseases. PLoS One. https://doi.org/10.1371/journal.pone.0152746
Okuda K, Nakajima K, Hosoya T, Ishikawa T, Konishi T, Matsubara K et al (2011) Semi-automated algorithm for calculating heart-to-mediastinum ratio in cardiac Iodine-123 MIBG imaging. J Nucl Cardiol 18(1):82–89
Owenius R, Zanette M, Cella P (2017) Variability in heart-to-mediastinum ratio from planar [123I]MIBG images of a thorax phantom for 6 common gamma-camera models. J Nucl Med Technol 45(4):297–303
Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W et al (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30(12):1591–1601
Ramsay SC, Cuscaden C (2020) The current status of quantitative SPECT/CT in the assessment of transthyretin cardiac amyloidosis. J Nucl Cardiol 27(5):1464–1468
Saito S, Nakajima K, Edenbrandt L, Enqvist O, Ulen J, Kinuya S (2021) Convolutional neural network-based automatic heart segmentation and quantitation in [123I]metaiodobenzylguanidine SPECT imaging. EJNMMI Res 11(1):105
Saito S, Nakajima K, Shibutani T, Wakabayashi H, Yoneyama H, Konishi T et al (2023) Three-dimensional heart segmentation and absolute quantitation of cardiac [123I]metaiodobenzylguanidine sympathetic imaging using SPECT/CT. Ann Nucl Cardiol 9(1):61–67
Travin MI, Henzlova MJ, van Eck-Smit BLF, Jain D, Carrio I, Folks RD et al (2017) Assessment of [123I]mIBG and [99mTc]tetrofosmin single-photon emission computed tomographic images for the prediction of arrhythmic events in patients with ischemic heart failure: intermediate severity innervation defects are associated with higher arrhythmic risk. J Nucl Cardiol 24(2):377–391
Verschure DO, Nakajima K, Verberne HJ (2022) Cardiac [123I]mIBG imaging in heart failure. Pharmaceuticals (basel) 15(6):656
Yamada M, Komatsu J, Nakamura K, Sakai K, Samuraki-Yokohama M, Nakajima K et al (2020) Diagnostic criteria for dementia with lewy bodies: updates and future directions. J Mov Disord 13(1):1–10
Acknowledgements
The authors appreciate Hiroto Yoneyama and Takahiro Konishi (Kanazawa University Hospital, Kanazawa, Japan) for technical assistance. We also thank Norma Foster (English Express, North Vancouver, BC, Canada) for editorial assistance.
Funding
This study was partly funded by a G-7 Scholarship Foundation and JSPS Grant-in-Aid for Early-Career Scientists in Japan (PI: S. Saito, No. 22K15801) and for Scientific Research (C) in Japan (PI: K. Nakajima, No. 20K07990 and 23K07203).
Author information
Authors and Affiliations
Contributions
SS and KN designed and summarized the study. JK classified the neurological diagnoses in accordance with the recommended criteria. TS provided technical support for SPECT-CT data acquisition. SS statistically analyzed the data, and KN confirmed the statistical outcomes. SS drafted, and KN, JK, HW, and HM revised the manuscript. AT acquired the clinical data. KO and SK supervised the study. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The Ethics Committee at Kanazawa University approved this retrospective study of data, and waived the need for written informed consent from the patients.
Consent for publication
Informed consent including publication was obtained from all patients in the form of opt-out.
Competing interests
KN is in a research collaboration with PDRadiopharma, Inc. Tokyo, Japan, which supplied the [123I]MIBG. All other authors declare that they have no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Saito, S., Nakajima, K., Komatsu, J. et al. Absolute quantitation of sympathetic nerve activity using [123I] metaiodobenzylguanidine SPECT-CT in neurology. EJNMMI Rep. 8, 15 (2024). https://doi.org/10.1186/s41824-024-00205-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s41824-024-00205-9